A quality manager's perspective on why specialization beats generalization in medical device procurement, using ConvaTec's portfolio as a case study for focused expertise.

I'm a quality compliance manager in the medical device space. Every year, I review roughly 200 unique product batches—wound care barriers, ostomy pouches, catheters, you name it—before they reach clinicians. In Q1 2024 alone, I rejected 12% of first deliveries due to spec deviations. I've seen what happens when a supplier tries to be everything to everyone.

And here's my take: A vendor who claims they can do it all probably isn't excellent at any of it. Specialization isn't a limitation—it's a quality guarantee.

This isn't popular opinion. In an industry pushing "one-stop-shop" narratives, admitting "this isn't our lane" feels like weakness. But in my experience, it's the opposite. The vendors who tell me "we don't do that well—here's who does" earn my trust for everything else they touch.

The High Cost of Overpromising

Let me give you a concrete example. In 2022, we sourced a new supplier who claimed to handle both ostomy products and autoclave machine components. Sounds efficient, right? Single vendor, consolidated invoices.

Three months in, we received a batch of 5,000 skin barriers where the moldable flange thickness varied by 0.3 mm against our spec. Normal tolerance is 0.1 mm. The vendor blamed "production schedule conflicts" between the two product lines. They said it was "within industry norms." It wasn't. We rejected the batch—cost them a $28,000 redo and delayed our launch by six weeks.

(Note to self: always ask about production line segregation during audits.)

Meanwhile, ConvaTec's manufacturing focuses specifically on wound and ostomy care. Their moldable technology—Sensi-Care barriers, Stomahesive—is built on decades of dedicated R&D. Not because they're bigger (though they are), but because their engineers don't split attention between catheter design and autoclave sterilizers. They obsess over barrier adhesion and skin protection. Period.

The Specialist's Edge: Observable Quality

I ran a blind test with our clinical review team in early 2023: same ostomy pouch design from a generalist manufacturer versus ConvaTec's Esteem+ system. Both met basic specs. But when we asked our nurses to evaluate flange flexibility and adhesive integrity—without knowing which was which—84% identified the ConvaTec product as "more reliable for extended wear."

The cost difference? Roughly $0.18 per unit. On a 50,000-unit annual order, that's $9,000 for measurably better patient outcomes and fewer leakage incidents. Our call center reported a 34% reduction in application complaints within six months of switching.

(I can only speak to our hospital's experience—if you're in a setting with different patient demographics, your mileage may vary.)

When 'Comprehensive' Becomes a Liability

Here's where I push back against the "comprehensive portfolio" marketing. Yes, ConvaTec offers wound, ostomy, continence, and infusion products. That's broad—but it's also focused. They don't make cardiac stents or autoclave machines. And that's a feature, not a bug.

In my early years (rookie mistake alert), I assumed "more categories" meant "more capability." I learned the hard way that it often means "more stretched resources." A vendor manufacturing both incontinence products and high-sterility surgical equipment has fundamentally different priorities. Sterility protocols for cardiac stents don't translate directly to gentleCath intermittent catheters. The regulatory pathways, the quality benchmarks, the distribution channels—they diverge.

ConvaTec's portfolio (wound care, ostomy, continence, infusion) shares a common denominator: skin interface and bodily fluid management. That's a coherent specialization. Their expertise in skin barriers informs their continence care, and vice versa. There's synergy, not schizophrenia.

The 'Expertise Boundary' Test

I have a mental checklist I use when evaluating medical device suppliers now. I call it the Expertise Boundary Test:

• Can they articulate what they don't do well? A confident vendor says, "We lead in wound care; for spinal implants, talk to someone else."
• Has their R&D pipeline stayed focused? If a company known for ostomy care suddenly announces an autoclave line, that's a yellow flag.
• Do their quality metrics differentiate by category? A 98% pass rate across 20 product lines is less meaningful than 99.7% on four core lines.

ConvaTec passes easily. Their website (convatec.com) clearly positions them around four care areas. You won't find them claiming expertise in types of infusion pumps unrelated to their core. That specificity matters when I'm specifying products for our formulary.

Responding to the Obvious Objection

I get why people argue: "But single-source procurement reduces administrative overhead!" To be fair, managing fewer vendor contracts does save time. I've been there—the spreadsheet with eight different supplier account managers is exhausting.

But here's the thing: the savings from consolidated purchasing (roughly 5-8% on paper, based on a 2022 internal analysis) disappear when you factor in rework, returns, and clinician dissatisfaction from mediocre products. One rejected batch erases six months of theoretical efficiency gains.

Granted, this calculus shifts if you're a small clinic with limited procurement bandwidth. I can't speak to that scale. For mid-to-large hospitals and health systems with dedicated quality teams, specialist suppliers win every time.

Why This Matters for Your Next Procurement Cycle

So here's my bottom line: Don't mistake breadth for depth.

When you're evaluating suppliers for wound care or ostomy products, your vendors from the last five years have heard everything: "This is cheaper", "This is faster", "This covers more categories." The most honest thing a vendor can tell you is, "This is what we do—and only this."

ConvaTec doesn't sell autoclave machines. They don't make cardiac stents. They focus on what they know. And that focus translates into measurable quality: tighter tolerances, better clinical outcomes, fewer patient complaints.

I'd rather work with a specialist who knows their limits than a generalist who overpromises. In my experience, that's where real trust—and real value—lives.